First case of mirtazepine-induced Stevens-Johnson syndrome from India

A 28-year-old woman, a known case of systemic lupus erythematosus (SLE), was admitted with mucocutaneous ulceroerosive lesions with blisters and thrombocytopenia after taking antidepressant mirtazepine. Exacerbation of SLE and drug-induced eruption was diagnosed. Clinical and laboratory markers were...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhasin, Amit, Gurtoo, Anil, Gupta, Latika, Aggarwal, Gunjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Drug Watch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480806/
https://www.ncbi.nlm.nih.gov/pubmed/23112435
http://dx.doi.org/10.4103/0253-7613.100411
_version_ 1782247628434571264
author Bhasin, Amit
Gurtoo, Anil
Gupta, Latika
Aggarwal, Gunjan
author_facet Bhasin, Amit
Gurtoo, Anil
Gupta, Latika
Aggarwal, Gunjan
author_sort Bhasin, Amit
collection PubMed
description A 28-year-old woman, a known case of systemic lupus erythematosus (SLE), was admitted with mucocutaneous ulceroerosive lesions with blisters and thrombocytopenia after taking antidepressant mirtazepine. Exacerbation of SLE and drug-induced eruption was diagnosed. Clinical and laboratory markers were suggestive of Stevens-Johnson syndrome. This is a rare adverse effect of the newer generation antidepressant mirtazepine.
format Online
Article
Text
id pubmed-3480806
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-34808062012-10-30 First case of mirtazepine-induced Stevens-Johnson syndrome from India Bhasin, Amit Gurtoo, Anil Gupta, Latika Aggarwal, Gunjan Indian J Pharmacol Drug Watch A 28-year-old woman, a known case of systemic lupus erythematosus (SLE), was admitted with mucocutaneous ulceroerosive lesions with blisters and thrombocytopenia after taking antidepressant mirtazepine. Exacerbation of SLE and drug-induced eruption was diagnosed. Clinical and laboratory markers were suggestive of Stevens-Johnson syndrome. This is a rare adverse effect of the newer generation antidepressant mirtazepine. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3480806/ /pubmed/23112435 http://dx.doi.org/10.4103/0253-7613.100411 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Drug Watch
Bhasin, Amit
Gurtoo, Anil
Gupta, Latika
Aggarwal, Gunjan
First case of mirtazepine-induced Stevens-Johnson syndrome from India
title First case of mirtazepine-induced Stevens-Johnson syndrome from India
title_full First case of mirtazepine-induced Stevens-Johnson syndrome from India
title_fullStr First case of mirtazepine-induced Stevens-Johnson syndrome from India
title_full_unstemmed First case of mirtazepine-induced Stevens-Johnson syndrome from India
title_short First case of mirtazepine-induced Stevens-Johnson syndrome from India
title_sort first case of mirtazepine-induced stevens-johnson syndrome from india
topic Drug Watch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480806/
https://www.ncbi.nlm.nih.gov/pubmed/23112435
http://dx.doi.org/10.4103/0253-7613.100411
work_keys_str_mv AT bhasinamit firstcaseofmirtazepineinducedstevensjohnsonsyndromefromindia
AT gurtooanil firstcaseofmirtazepineinducedstevensjohnsonsyndromefromindia
AT guptalatika firstcaseofmirtazepineinducedstevensjohnsonsyndromefromindia
AT aggarwalgunjan firstcaseofmirtazepineinducedstevensjohnsonsyndromefromindia

Ejemplares similares